CTSDMC staff were in attendace at the 40th Annual Meeting of the Society for Clinical Trials (SCT) this week. The meeting - hosted in New Orleans, LA, May 19-22, 2019 - featured two invited sessions...
CTSDMC contributes to 2019 Abstract of Distinction
A research abstract from the Parkinson's Progression Markers Initiative (PPMI) has been selected by the American Academy of Neurology as a "2019 AAN Abstract of Distinction." The Abstracts of...
New multiple sclerosis drug slows brain shrinkage, study shows
A new drug has been shown to slow brain shrinkage in multiple sclerosis patients, according to a new preliminary trial conducted in part with the University of Iowa. The UI's Clinical Trials...
Study finds drug slows brain shrinkage in people with MS
A recent study published in the New England Journal of Medicine found that the drug ibudilast slows down brain shrinkage in people with multiple sclerosis (MS). Clinical trial results showed that...
NIH NeuroNEXT renewal includes expanded role for UI clinical research
The University of Iowa is expanding its role in a network of neurological research centers funded by the National Institutes of Health. The NIH announced a renewal of funding for Network for...
Islet transplantation improves quality of life for people with type 1 diabetes
Quality of life for people with type 1 diabetes who had frequent severe hypoglycemia--a potentially fatal low blood sugar level--improved consistently and dramatically following transplantation of...
Video: CTSDMC helps research move forward
Clinical trials for neurological diseases are long and arduous. See how the Clinical Trials and Statistical Data Management Center at the University of Iowa is helping to simplify the process by...
CTSDMC contributes to groundbreaking neurological research through NeuroNEXT
NeuroNEXT, a national network funded by the National Institutes of Health and led by the University of Iowa, is accelerating the clinical trial process for neurological diseases with the expectation...
Pediatric migraine study selected for “Best Advances of 2017”
A study of the impact of medication on children's migraine headaches, co-led by the UI's Christopher Coffey, has been named one of the leading developments in neuroscience in 2017 by the journal...